Mukdahan International Hospital Public Company Limited

As of June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR carries a market capitalization of 498.40M, placing it among publicly traded companies globally. Its enterprise value stands at 439.85M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR has 560.00M shares outstanding.

As of June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR trades at a trailing price-to-earnings ratio of 80.29. The price-to-sales ratio is 1.11, and the price-to-book ratio stands at 1.63.

As of June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR trades at an EV/EBITDA multiple of 9.01 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.98 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 50.50 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Mukdahan International Hospital Public Company Limited NVDR trades at an EV/FCF ratio of 19.94, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 439.85M versus a market cap of 498.40M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR maintains a current ratio of 2.24, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 20.34, indicating elevated leverage, while an interest coverage ratio of 16.92 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR posted a return on equity (ROE) of 2.49, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 2.33 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 1.66, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 2.73, useful for judging operating efficiency across full business cycles. Inventory turnover of 18.44 indicates how many times Mukdahan International Hospital Public Company Limited NVDR sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR recorded 1.12M in income tax expense. That works out to an effective tax rate of 15.24, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 7.32M, leaving 6.21M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Mukdahan International Hospital Public Company Limited NVDR's stock has declined approximately 26.85% over the past 52 weeks. The 50-day moving average sits at 0.81, while the 200-day moving average is 0.90.

Over the twelve months ended June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR generated 450.75M in revenue and converted that into 6.21M in net income, yielding earnings per share of 0.01. EBITDA reached 48.83M, while operating income came in at 8.71M.

As of June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR holds 120.92M in cash and equivalents against 62.37M in total debt, resulting in a net debt position of -71.87M. Total book value stands at 306.59M, with working capital of 101.08M providing operational flexibility.

Mukdahan International Hospital Public Company Limited NVDR produced 47.21M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -27.60M in capital expenditures, free cash flow totaled 19.62M - equivalent to 0.04 per share.

Over the twelve months ended June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR posted a gross margin of 27.54, reflecting its pricing power and cost economics. The operating margin of 1.93 and net profit margin of 1.38 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 3.94, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -18.74, meaning Mukdahan International Hospital Public Company Limited NVDR raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Mukdahan International Hospital Public Company Limited NVDR has an Altman Z-Score of 3.92, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.